10 Recipes Cozier Than a Weighted Blanket

When temperatures drop below freezing, nothing soothes quite like cheesy toasts or heaping piles of pasta. Let comforting beige food reign, and make a few of our most popular recipes from this week. Break out the blender for a creamy cauliflower soup topped with croutons and fragrant rosemary olive oil, or pull out the sheet…

Health and Wellness Gifts for Couples

Every January we collectively set intentions to become better versions of ourselves. With the desire to refresh, reset and renew at the forefront of everyone’s mind, many couples use the top of the year as a time to establish their own health and relationship goals. We checked in with four leading fitness gurus, wellness influencers…

Nitrous Nation: A Party Drug Endures

For decades, nitrous oxide has been widespread at raves and music festivals, used as a quick buzz. The drug doesn’t have the death toll of the opiate disaster or the widespread popularity of marijuana, but it’s widely sold — legally — all over the country, though its consumption outside medical facilities is illegal in many…

MacKenzie Scott, Melinda Gates, Priscilla Chan: On Women Philanthropists

“The effort that goes into motivating volunteers and building community spirit can be dismissed as ‘merely’ sociable interchange, related to women’s gender roles and natural propensities, requiring no real skills,” wrote the study’s author, Arlene Kaplan Daniels. “Women who engaged in philanthropy were the behind-the-scenes volunteers, the unrecognized work,” said Debra Mesch, a professor of…

Selected gene mRNA expression is not predictive of improved overall survival

(Singapore–January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)– A phase III study examining whether messenger (m)RNA expression correlated with sensitivity or resistance to chemotherapy did not confer a statistically significant advantage in overall survival for patients with resected stage II-III non-small cell lung cancer (NSCLC), according to research presented at the International…

LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate

(Singapore–January 30, 2021 11:00 p.m. SPT/January 30, 2021 10:00 a.m. EST)– Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated by patients and met its primary endpoint of 20% major pathologic response rate, according to research presented today at the International…